INFLAMMATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-01-02 杰夫杨

好慢啊，，一个月了还没送审，，，

78 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-12-14 ms8000002147269774 来自江西省

各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！

47 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2021-12-16 12509f90m28暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。

77 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-05-08 165409041

这个投完后在哪看稿件状态？

54 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2021-03-29 12500618m15暂无昵称

请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂

99 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-04-13 ms3000001477611387

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：炎症
经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费

74 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-07-11 v001kevin

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：炎症
经验分享：5b,2,836.00 USD,有点小贵啊

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-10-22 ms3000001880616001

投稿命中率:75.0
经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办

46 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-10-25 小可爱的

能接受生信➕验证的文章吗

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1179669, encodeId=08ae11e966988, content=好慢啊，，一个月了还没送审，，， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22155559271, createdName=杰夫杨, createdTime=Sun Jan 02 00:10:33 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106092, encodeId=7d74210609250, content=各位大佬请问这个杂志Gels and bolts需要 uncropped version，意思是一张膜跑一个蛋白指标吗？我们的都是剪了之后分别跑的，我上传了带market的蛋白图说还需要uncropped版本，没太懂什么意思，跪求解答！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4c8414843, createdName=ms8000002147269774, createdTime=Wed Dec 14 21:28:07 CST 2022, time=2022-12-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1080883, encodeId=bf6910808838c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大家都是选择OA还是非OA，OA费用3860美元，非常贵。另外选择彩图印刷额外1100美元，我选择了非OA，非彩色印刷，不知道啥时候On Line。主要费用太贵了。请各位战友支招。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49a82534143, createdName=12509f90m28暂无昵称, createdTime=Thu Dec 16 21:52:38 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217745, encodeId=d657121e74582, content=这个投完后在哪看稿件状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a004723635, createdName=165409041, createdTime=Sun May 08 00:10:38 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952060, encodeId=d2f1952060fb, content=请问各位大神，reviews completed后多久变化状态的？这个杂志真的有点太难了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/31/bbfccb6120c1c592b21167ed894e29e5.jpg, createdBy=536e2531116, createdName=12500618m15暂无昵称, createdTime=Mon Mar 29 15:40:47 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210913, encodeId=2f191210913f1, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：炎症 经验分享：再也别投了，大坑呀，太坑呀！！！！切记！！！投两年，还要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=876b6158686, createdName=ms3000001477611387, createdTime=Wed Apr 13 18:45:44 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231787, encodeId=6ec01231e873b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：5b,2,836.00 USD,有点小贵啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a35110822, createdName=v001kevin, createdTime=Mon Jul 11 14:43:46 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095430, encodeId=37052095430fc, content=投稿命中率:75.0 经验分享：想问一下，接受之后，进行协议什么的确认的时候，点了之后邮件发不过来，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f878231063, createdName=ms3000001880616001, createdTime=Sat Oct 22 20:11:55 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096138, encodeId=55ca20961386f, content=能接受生信➕验证的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/e46ee6b8004843a6bc90b491c388dbde/b538a1ea6c4749eda3c6632203fc3886.jpg, createdBy=40b95313759, createdName=小可爱的, createdTime=Tue Oct 25 22:01:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250285, encodeId=d0be125028528, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：哮喘;气道炎症 经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究 7月22号投稿， 7月23号退回要求提供WB原图， 7月25号再次上传，WB原图带marker，3次重复， 7月25号quality check通过，分配编辑， 可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易， 7月26第一个reviewer接受审稿 8月6号第二个reviewer接受审稿 8月6号第一个reviewer审稿完成 8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改 9月8号提交修回稿 9月9号文章接收 9月16号online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cc05700292, createdName=ms3000000082046520, createdTime=Sat Sep 17 16:13:21 CST 2022, time=2022-09-17, status=1, ipAttribution=)]

2022-09-17 ms3000000082046520

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：哮喘;气道炎症
经验分享：基础实验文章，包括动物实验和细胞实验，涉及免疫细胞研究
7月22号投稿，
7月23号退回要求提供WB原图，
7月25号再次上传，WB原图带marker，3次重复，
7月25号quality check通过，分配编辑，
可能由于我的文章属于杂志的主流研究方向，找审稿人比较容易，
7月26第一个reviewer接受审稿
8月6号第二个reviewer接受审稿
8月6号第一个reviewer审稿完成
8月31号编辑部发邮件告知审稿意见，小修，要求改善语言，给14天时间修改
9月8号提交修回稿
9月9号文章接收
9月16号online

44 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务